Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ka O. Lam"'
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Background: The fluoropyrimidine anticancer drug, especially 5- fluorouracil (5-FU) and its prodrug capecitabine are still being the backbone of chemotherapeutic regimens for colorectal cancer. Dihydropyrimidine dehydrogenase (DPD) is the crucial enz
Externí odkaz:
https://doaj.org/article/09eda661f1894a56ae53451d6b46d591
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Frontiers in Oncology
Frontiers in Oncology
Background: The fluoropyrimidine anticancer drug, especially 5- fluorouracil (5-FU) and its prodrug capecitabine are still being the backbone of chemotherapeutic regimens for colorectal cancer. Dihydropyrimidine dehydrogenase (DPD) is the crucial enz
Autor:
Maximino Bello, Joong B. Ahn, Hwai L. Kong, Su Z. Zhang, Michael Shaw, Fortunato Ciardiello, Jin Li, Virote Sriuranpong, Li-Tzong Chen, Ka O. Lam, Ann-Lii Cheng, Aru W Sudoyo, Young Suk Park, Jaw-Yuan Wang, Gwo F. Ho, Brigette B.Y. Ma, Ashok K. Vaid, Clause Henning Köhne, Jun Zhang, Tian S. Liu, Catherine Teh, Tae Won Kim, Chaiyut Charoentum, Gilberto Lopes
Publikováno v:
Clinical colorectal cancer. 13(3)
Colorectal cancer (CRC) is among the most common cancers worldwide, but marked epidemiological differences exist between Asian and non-Asian populations. Hence, a consensus meeting was held in Hong Kong in December 2012 to develop Asia-specific guide
Autor:
Ann-Lii Cheng, Jin Li, Vaid, Ashok K., Buig Yue Ma, Brigette, Teh, Catherine, Joong B. Ahn, Bello, Maximino, Chaiyut Charoentum, Li-Tzong Chen, de Lima Lopes, Gilberto, Gwo F. Ho, Hwai L. Kong, Ka O. Lam, Tian S. Liu, Young S. Park, Virote Sriuranpong, Sudoyo, Aru W., Jaw-Yuan Wang, Jun Zhang, Su Z. Zhang
Publikováno v:
Clinical Colorectal Cancer; Sep2014, Vol. 13 Issue 3, p145-155, 11p